|
Tapiz I Reula AJ, Cochino AV, Martins AL, Angosto-Bazarra D, de Landazuri IO, Mensa-Vilaro A, Cabral M, Baroja-Mazo A, Banos MC, Lobato-Salinas Z, Fabregat V, Plaza S, Yague J, Casals F, Oliva B, Figueiredo AE, Pelegrin P, Arostegui JI. Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome. J Clin Immunol. 2022 Oct;42(7):1421-1432. doi: 10.1007/s10875-022-01298-2. Epub 2022 Jun 18. Erratum In: J Clin Immunol. 2022 Jul 8;: PubMed PMID: 35716229; PubMed Central PMCID: PMC9674708.
AÑO: 2022; IF: 9.1
|
35716229
|
Lucas-Ruiz F, Mateo SV, Jover-Aguilar M, Alconchel F, Martinez-Alarcon L, de Torre-Minguela C, Vidal-Correoso D, Villalba-Lopez F, Lopez-Lopez V, Rios-Zambudio A, Pons JA, Ramirez P, Pelegrin P, Baroja-Mazo A. Danger signals released during cold ischemia storage activate NLRP3 inflammasome in myeloid cells and influence early allograft function in liver transplantation. EBioMedicine. 2023 Jan;87:104419. doi: 10.1016/j.ebiom.2022.104419. Epub 2022 Dec 19. PubMed PMID: 36543018; PubMed Central PMCID: PMC9794897.
AÑO: 2023; IF: 9.7
|
|
Baroja-Mazo A, Penin-Franch A, Lucas-Ruiz F, de Torre-Minguela C, Alarcon-Vila C, Hernandez-Caselles T, Pelegrin P. P2X7 receptor activation impairs antitumour activity of natural killer cells. Br J Pharmacol. 2023 Jan;180(1):111-128. doi: 10.1111/bph.15951. Epub 2022 Oct 3. PubMed PMID: 36098250; PubMed Central PMCID: PMC10092446.
AÑO: 2023; IF: 6.8
|
|
Lucas-Ruiz F, Penin-Franch A, Pons JA, Ramirez P, Pelegrin P, Cuevas S, Baroja-Mazo A. Emerging Role of NLRP3 Inflammasome and Pyroptosis in Liver Transplantation. Int J Mol Sci. 2022 Nov 19;23(22):14396. doi: 10.3390/ijms232214396. PubMed PMID: 36430874; PubMed Central PMCID: PMC9698208.
AÑO: 2022; IF: 5.6
|
|
Pizzuto M, Pelegrin P, Ruysschaert JM. Lipid-protein interactions regulating the canonical and the non-canonical NLRP3 inflammasome. Prog Lipid Res. 2022 Jul;87:101182. doi: 10.1016/j.plipres.2022.101182. Epub 2022 Jul 25. PubMed PMID: 35901922; PubMed Central PMCID: PMC7613582.
AÑO: 2022; IF: 13.6
|